President and CEO
Ken Paulus is a transformative leader with more than 30 years’ experience in the health care sector, building strategic partnerships, integrating payment and delivery systems, and implementing consumer-centric health care solutions. As president and CEO of Prime Therapeutics, Paulus is responsible for the strategic direction and operations of one of the nation’s premier total drug management companies, with more than 28 million members in commercial markets and government programs.
From 2005 to 2015, Paulus held leadership roles at Allina Health; including CEO, president and chief operating officer (COO). Based in Minneapolis, Allina is one of the nation’s largest, most seamlessly integrated health delivery systems. During his tenure, Paulus led Allina beyond traditional acute care and into improving health, home-based care, retail pharmacy, and management of complicated specialty and chronic disease.
Earlier in his career, Paulus served as president and CEO of Harvard Vanguard Medical Associates, the staff model partner of Harvard Pilgrim Healthcare in Boston. While at Harvard Vanguard, Paulus led creation of Atrius Health and served as the system’s first president and CEO. Prior to Atrius, he was COO of Partners Community Healthcare, the risk-bearing entity of Partners Healthcare System.
Most recently, Paulus served as an executive advisor with Water Street Healthcare Partners, a private equity firm focused on the health care sector, giving him yet another perspective on value and value creation. Paulus also serves on several boards of directors, including Breg Inc., Teladoc Health Inc and is a past chair of the Pharmaceutical Care Management Association (PCMA) Board of Directors.
Paulus earned a bachelor’s degree in biological sciences from Augustana College in Rock Island, Illinois, and a Master of Health Care Administration from the University of Minnesota in Minneapolis.
September 15, 2020
Washington, D.C. — Today, the Pharmaceutical Care Management Association (PCMA) announced Ken Paulus,…
May 6, 2021
EAGAN, Minn. – Prime Therapeutics LLC’s (Prime) President and CEO Ken Paulus is…
April 11, 2019
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced today that its board of…
January 27, 2020
Capital BlueCross advances its precision drug access & cost reduction initiatives with new pharmacy benefit manager
HARRISBURG, Pa. – As drug costs rise and new therapies bring both life-saving…